Azopharma’s inhalation and intranasal formulations development group assists our partners with the development of various inhalation dosage forms. Our exceptional scientists provide a full complement of analytical support for all inhalation and nasal spray dosage forms.

Formulation Development:

Azopharma provides formulation development services for solutions and suspensions in nebulization and nasal sprays. We also provide powder blend formulations for DPIs and pMDIs. Specific services include:

• Salt selection
• Solubility studies
• Excipient screening studies
• Chemical stability
• Prototype selection

Analytical Development:

Azopharma provides analytical development services for DPI, pMDI, nebulizers and nasal sprays. These services include:

• Method development/validation
• API characterization
• Physio-chemical testing

Performance Characterization Studies:

Azopharma provides performance characterization studies for DPI, pMDI, nebulizers and nasal sprays. Studies include:

• Particle sizing
• Plume geometry
• Aerodynamic by ACI
• Spray pattern
• Next Generation Impactor (NGI)
• Dose content
• Laser light scattering
• Uniformity
• Through life testing

Related Testing:

• Device and component evaluation
• Stability testing
• Extractable and leachable studies
• Supportive microbiology